TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 107 filers reported holding TARSUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,038,213 | +18.3% | 2,140,586 | +20.3% | 5.37% | +13.4% |
| Q2 2023 | $32,149,385 | +25.7% | 1,779,158 | -12.5% | 4.73% | +24.2% |
| Q1 2023 | $25,569,366 | -12.9% | 2,034,158 | +1.6% | 3.81% | -10.6% |
| Q4 2022 | $29,343,236 | -18.0% | 2,001,585 | -4.2% | 4.26% | -2.8% |
| Q3 2022 | $35,778,000 | +17.6% | 2,089,856 | +0.3% | 4.39% | -5.0% |
| Q2 2022 | $30,432,000 | +503.1% | 2,084,370 | +594.8% | 4.62% | +357.7% |
| Q1 2022 | $5,046,000 | – | 300,000 | – | 1.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,140,586 | $38,038,213 | 5.37% |
| Vivo Capital, LLC | 2,262,200 | $40,199,294 | 4.40% |
| TCG Crossover Management, LLC | 1,142,857 | $20,308,569 | 2.99% |
| Cormorant Asset Management, LP | 2,621,422 | $46,582,669 | 2.72% |
| Ghost Tree Capital, LLC | 400,000 | $7,108,000 | 2.34% |
| COWEN AND COMPANY, LLC | 1,796,773 | $31,928,656 | 2.23% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $31,764,355 | 2.11% |
| TFG Asset Management GP Ltd | 615,000 | $10,928,550 | 1.99% |
| Sands Capital Ventures, LLC | 260,000 | $4,620,200 | 1.37% |
| Ikarian Capital, LLC | 518,519 | $9,214,083 | 1.11% |